Huang Y, Gao Y, Lin Z, Miao H
Genes Dis. 2025; 12(2):101240.
PMID: 39759114
PMC: 11697063.
DOI: 10.1016/j.gendis.2024.101240.
Liu Y, Gao Q, Zhang Q, Li C, Liu S, Su M
Poult Sci. 2024; 104(1):104633.
PMID: 39693965
PMC: 11719366.
DOI: 10.1016/j.psj.2024.104633.
Doria-Belenguer S, Xenos A, Ceddia G, Malod-Dognin N, Przulj N
Bioinform Adv. 2024; 4(1):vbae075.
PMID: 38827411
PMC: 11142626.
DOI: 10.1093/bioadv/vbae075.
Kirat D, Alahwany A, Arisha A, Abdelkhalek A, Miyasho T
Cells. 2023; 12(9).
PMID: 37174722
PMC: 10177121.
DOI: 10.3390/cells12091322.
Sump B, Brickner J
Front Mol Biosci. 2022; 9:977653.
PMID: 36120540
PMC: 9479176.
DOI: 10.3389/fmolb.2022.977653.
Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer.
Schnepp P, Ahmed A, Escara-Wilke J, Dai J, Shelley G, Keller J
BMC Cancer. 2021; 21(1):1316.
PMID: 34879849
PMC: 8653542.
DOI: 10.1186/s12885-021-09048-0.
Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.
Onaolapo O, Onaolapo A, Olowe O, Udoh M, Udoh D, Nathaniel T
Curr Neuropharmacol. 2019; 18(7):563-577.
PMID: 31885352
PMC: 7457420.
DOI: 10.2174/1570159X18666191230114339.
Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?.
Valletti A, Marzano F, Pesole G, Sbisa E, Tullo A
Int J Mol Sci. 2019; 20(7).
PMID: 30974870
PMC: 6479553.
DOI: 10.3390/ijms20071776.
Lysine methylation of transcription factors in cancer.
Han D, Huang M, Wang T, Li Z, Chen Y, Liu C
Cell Death Dis. 2019; 10(4):290.
PMID: 30926778
PMC: 6441099.
DOI: 10.1038/s41419-019-1524-2.
CIC protein instability contributes to tumorigenesis in glioblastoma.
Bunda S, Heir P, Metcalf J, Li A, Agnihotri S, Pusch S
Nat Commun. 2019; 10(1):661.
PMID: 30737375
PMC: 6368580.
DOI: 10.1038/s41467-018-08087-9.
Non-Invasive Approaches to Epigenetic-Based Sperm Selection.
Stiavnicka M, Abril-Parreno L, Nevoral J, Kralickova M, Garcia-Alvarez O
Med Sci Monit. 2017; 23:4677-4683.
PMID: 28961228
PMC: 5633068.
DOI: 10.12659/msm.904098.
Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome.
Lim J, Lima P, Salehi R, Lee D, Tsang B
Sci Rep. 2017; 7(1):10272.
PMID: 28860512
PMC: 5578986.
DOI: 10.1038/s41598-017-09880-0.
Multifactorial Regulation of G Protein-Coupled Receptor Endocytosis.
Zhang X, Kim K
Biomol Ther (Seoul). 2016; 25(1):26-43.
PMID: 28035080
PMC: 5207461.
DOI: 10.4062/biomolther.2016.186.
MDM2 facilitates adipocyte differentiation through CRTC-mediated activation of STAT3.
Hallenborg P, Siersbaek M, Barrio-Hernandez I, Nielsen R, Kristiansen K, Mandrup S
Cell Death Dis. 2016; 7(6):e2289.
PMID: 27362806
PMC: 5108339.
DOI: 10.1038/cddis.2016.188.
Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancer.
Yuan B, Cheng L, Gupta K, Chiang H, Gupta H, Sareddy G
Oncotarget. 2016; 7(27):42585-42597.
PMID: 27323858
PMC: 5173158.
DOI: 10.18632/oncotarget.10018.
The Ubiquitination of NF-κB Subunits in the Control of Transcription.
Collins P, Mitxitorena I, Carmody R
Cells. 2016; 5(2).
PMID: 27187478
PMC: 4931672.
DOI: 10.3390/cells5020023.
Glycogen synthase kinase-3-mediated phosphorylation of serine 73 targets sterol response element binding protein-1c (SREBP-1c) for proteasomal degradation.
Dong Q, Giorgianni F, Beranova-Giorgianni S, Deng X, OMeally R, Bridges D
Biosci Rep. 2015; 36(1):e00284.
PMID: 26589965
PMC: 4718510.
DOI: 10.1042/BSR20150234.
TRIM26 negatively regulates interferon-β production and antiviral response through polyubiquitination and degradation of nuclear IRF3.
Wang P, Zhao W, Zhao K, Zhang L, Gao C
PLoS Pathog. 2015; 11(3):e1004726.
PMID: 25763818
PMC: 4357427.
DOI: 10.1371/journal.ppat.1004726.
DNA-damage-inducible 1 protein (Ddi1) contains an uncharacteristic ubiquitin-like domain that binds ubiquitin.
Nowicka U, Zhang D, Walker O, Krutauz D, Castaneda C, Chaturvedi A
Structure. 2015; 23(3):542-557.
PMID: 25703377
PMC: 4448915.
DOI: 10.1016/j.str.2015.01.010.
Synthesis and structure-activity relationship studies of N-benzyl-2-phenylpyrimidin-4-amine derivatives as potent USP1/UAF1 deubiquitinase inhibitors with anticancer activity against nonsmall cell lung cancer.
Dexheimer T, Rosenthal A, Luci D, Liang Q, Villamil M, Chen J
J Med Chem. 2014; 57(19):8099-110.
PMID: 25229643
PMC: 4191588.
DOI: 10.1021/jm5010495.